Certified Dinner Symposium: Improving Outcomes for Patients With Advanced Urothelial Carcinoma of the Bladder
(This activity is supported by educational grants from Astellas, Seattle Genetics and Merck Sharp & Dohme Corp.) Ticketed event. Limited seating.

Speaker(s)

• 

  Petros Grivas, MD, PhD

  Associate Professor
  University of Washington/Seattle Cancer Care Alliance
• 

  Jeannette Hammond, PA-C

  GU Medical Oncology, Teaching Associate, University of Washington, APP Professional Development Manager
  Seattle Cancer Care

This activity is supported by educational grants from Astellas, Seattle Genetics and Merck Sharp & Dohme Corp.

Learning Objectives:

• Evaluate data regarding mechanistic activity, efficacy, and safety of approved and emerging therapies for advanced or metastatic urothelial carcinoma
• Select appropriate lines of therapy for advanced or metastatic urothelial carcinoma in accordance with evidence-based best practices
• Plan strategies for managing adverse events associated with approved and emerging therapies for urothelial carcinoma